DOI: 10.1055/s-00000007

Aktuelle Urologie

References

Balar AV, Galsky MD, Rosenberg JE. et al.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.

Lancet 2017;
389: 67-76

Download Bibliographical Data

Access:
Access: